Navigation Links
Hospital Testing for Drug-Resistant Infections Dramatically Lowers Mortality Rates and Costs

New Study Shows Benefits in Patients Diagnosed with Staphylococcal, HIV, Tuberculosis and Other Infectious Diseases

WASHINGTON, March 4 /PRNewswire-USNewswire/ -- Testing hospitalized patients for drug-resistant infections can reduce mortality, decrease length of stay and reduce cost of care, according to a new report released today by AdvaMed, the Advanced Medical Technology Association. The report describes how diagnostic testing can identify drug resistance, allowing physicians to adjust medications or take other steps to more effectively treat patients with staphylococcal (staph) and other infectious diseases such as HIV and tuberculosis.

"These findings show such large benefits in cost savings and health outcomes that antimicrobial susceptibility tests should be performed on all patients with these diagnoses," said report author Frank Lichtenberg, Ph.D., Courtney C. Brown Professor of Business, Columbia University Graduate School of Business. "Widespread testing for drug-resistant infections is a small investment that yields high returns for patients, for hospitals and for the health care system overall."

The potential impact of testing for drug-resistant infections is significant as the number of U.S. hospital discharges that include a diagnosis of infection with a drug-resistant microorganism has increased more than 100-fold from 1993-2005 -- from 3,000 to 394,000.

"Dr. Lichtenberg's report provides further evidence of the incredible benefits to patients and the value provided to the health care system from diagnostic testing," said Stephen J. Ubl, president and CEO of AdvaMed. "These technologies are the foundation of the personalized medicine revolution that match the best treatment option with each individual patient. State-of-the-art diagnostic testing will help dramatically lower health care costs by eliminating unnecessary or ineffective treatments, but more importantly providing patients with the right treatment sooner."

The report indicates that patients tested for antimicrobial susceptibility had significantly lower mortality rates, lengths of stay, and overall treatment costs than patients who were not tested.

Key findings include:

-- Among patients with a secondary staph infection diagnosis, those tested for antimicrobial susceptibility had 52 percent lower probability of death before discharge, 17 percent lower mean length of stay (-1.8 days), and 22 percent lower cost than those who did not. Antimicrobial testing in this group was associated with $6,978 lower cost per discharge. The potential aggregate cost reduction from antimicrobial susceptibility testing of all patients hospitalized with this diagnosis in 2005 was $8.3 billion.

-- Among patients with any infectious and parasitic disease diagnosis, those tested for antimicrobial susceptibility had 30 percent lower probability of death before discharge, 26 percent lower mean length of stay (-1.8 days), and 36 percent lower cost than those who did not. Antimicrobial susceptibility testing in this group is associated with $7,524 lower cost per discharge.

To access a copy of the full report, please visit the News Room section of AdvaMed's Web site at

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
2. Risk of surgery for lung cancer lower at teaching hospitals
3. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
4. Anthem Blue Cross and Blue Shields Promoting Healthcare Quality Program Improves Quality and Patient Safety in 19 Colorado Hospitals
5. Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Childrens Hospital at Stanford
6. APIC Issues Recommendations on How to Have a Healthy Hospital Stay
7. AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals
8. AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital
9. St. Louis University Hospital Purchases Second CyberKnife(R) System
10. Black VLBW babies in NYC more likely to be born in hospitals with high neonatal death rates
11. UPDATED: Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology: